Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Wednesday, July 8, 2026
🇺🇸 FDA

venetoclax News

🇺🇸 FDA ← All news

FDA venetoclax coverage for business development, investment, and market access teams

Critical impact NewsMay 1, 2026

Eli Lilly's Foundayo (Orforglipron) Receives FDA Approval for Obesity Treatment as Company Reports Strong Q1 2026 Results

Metabolic disorders and oncology · 3 min

Daniel Brooks

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.